Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Metseras pipeline includes MET-097i, a GLP-1 receptor agonist designed for once-monthly dosing, and MET-233i, an amylin analog being developed for monthly administration
* Correspondence: Malavika E
Additionally, expanding indications aims to tap into new markets
What Makes the Ivm Health Model Different Ivim Healths GLP-1 ID program includes several key components working together: Medical oversight from board-certified obesity medicine physicians who understand the complexities of weight management during perimenopause Flexible provider access for timely dose adjustments and side effect management when you need it Functional health coaching to support nutrition, lifestyle optimization, and sustainable habits Community connection where you can share experiences with others on similar journeys Progress tracking tools through the Ivm Health app to monitor your results and identify patterns This integrated approach combines clinical expertise with personalized support, something thats particularly valuable when navigating the metabolic changes of perimenopause
These medications are known as GLP-1s, short for glucagon-like 1-peptide receptor agonists
Changing the frequency of your injections, though, should only be done at the direction of your clinician
US$ 22.64
US$ 27.78
US$ 20.18
US$ 26.86
US$ 23.70
US$ 24.29
US$ 27.42
US$ 24.06
US$ 26.04
US$ 25.61
US$ 24.80
US$ 28.33
US$ 20.93
US$ 23.87
US$ 21.29
US$ 24.37
